Michael F Maclean Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 8 hours ago
Michael F Maclean has an estimated net worth of at least $17.8 million*, as of Aug. 27, 2025. They own 65,806 shares of RNA stock. They have sold 403,205 shares of RNA stock since 2021, for an estimated $14.7 million.
Michael F Maclean $RNA SEC Form 4 Insider Trading
Michael F Maclean has filed a total of 14 insider trades in $RNA since 2021. Their most recent trade was a sale of 30,914 shares, made on Aug 06, 2025. Their largest trade was a sale of 104,245 shares, made on Jun 12, 2024. We estimate that they now own 65,806 shares of $RNA, worth an estimated $3.1 million.
Insider Trading at $RNA
There have been a total of 130 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.7 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Arthur A Levin, and Michael F Maclean. The most recent trade was a sale of 25,000 shares reported by Sarah Boyce (President and CEO), made on Aug 28, 2025.
History of Insider Stock Trades by Michael F Maclean
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
RNA
|
Sale | 30,914 | Aug 06, 2025 | Aug. 15, 2025, 4:09 p.m. |
|
RNA
|
Sale | 7,935 | Mar 20, 2025 | March 21, 2025, 6:38 p.m. |
|
RNA
|
Sale | 1,622 | Jan 21, 2025 | Jan. 23, 2025, 9:15 p.m. |
|
RNA
|
Sale | 1,665 | Jan 21, 2025 | Jan. 23, 2025, 9:15 p.m. |
|
RNA
|
Sale | 11,151 | Dec 18, 2024 | Dec. 19, 2024, 7:16 p.m. |
|
RNA
|
Sale | 27,262 | Nov 06, 2024 | Nov. 8, 2024, 5:50 p.m. |
|
RNA
|
Sale | 65,182 | Nov 06, 2024 | Nov. 8, 2024, 5:50 p.m. |
|
RNA
|
Sale | 13,875 | Nov 06, 2024 | Nov. 8, 2024, 5:50 p.m. |
|
RNA
|
Sale | 11,510 | Sep 23, 2024 | Sept. 23, 2024, 8:59 p.m. |
|
RNA
|
Sale | 11,228 | Jun 18, 2024 | June 20, 2024, 6:48 p.m. |
|
RNA
|
Sale | 104,245 | Jun 12, 2024 | June 14, 2024, 7:07 p.m. |
|
RNA
|
Sale | 75,000 | May 14, 2024 | May 16, 2024, 6:25 p.m. |
|
RNA
|
Sale | 40,000 | Mar 13, 2024 | March 15, 2024, 4:12 p.m. |
|
RNA
|
Sale | 1,616 | Jan 22, 2024 | Jan. 23, 2024, 4:11 p.m. |
$RNA Executives and Stock Owners with Insider Trades
-
Sarah Boyce, President and CEO
-
Arthur A Levin, Chief Scientific Officer
-
Michael F Maclean, Chief Financial Officer
-
Teresa Mccarthy, Chief Human Resources Officer
-
Kathleen P. Gallagher, Chief Program Officer
-
Steven George Hughes, Chief Medical Officer
-
W. Michael Flanagan, CSTO
-
W. Michael Flanagan, Chief Scientific Officer
-
Eric Mosbrooker, Chief Commercial Officer
-
John B Moriarty, Chief Legal Officer
-
Roderick Wong, MP and CIO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.